2rmy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:54, 20 December 2023) (edit) (undo)
 
Line 1: Line 1:
==Structure of the N-terminal BARpeptide in SDS micelles==
==Structure of the N-terminal BARpeptide in SDS micelles==
-
<StructureSection load='2rmy' size='340' side='right'caption='[[2rmy]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''>
+
<StructureSection load='2rmy' size='340' side='right'caption='[[2rmy]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[2rmy]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RMY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2RMY FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[2rmy]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RMY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2RMY FirstGlance]. <br>
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2rmy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2rmy OCA], [https://pdbe.org/2rmy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2rmy RCSB], [https://www.ebi.ac.uk/pdbsum/2rmy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2rmy ProSAT]</span></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2rmy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2rmy OCA], [https://pdbe.org/2rmy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2rmy RCSB], [https://www.ebi.ac.uk/pdbsum/2rmy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2rmy ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
-
[[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN]] Defects in BIN1 are the cause of centronuclear myopathy type 2 (CNM2) [MIM:[https://omim.org/entry/255200 255200]]. A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.<ref>PMID:17676042</ref>
+
[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN] Defects in BIN1 are the cause of centronuclear myopathy type 2 (CNM2) [MIM:[https://omim.org/entry/255200 255200]. A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.<ref>PMID:17676042</ref>
== Function ==
== Function ==
-
[[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN]] May be involved in regulation of synaptic vesicle endocytosis. May act as a tumor suppressor and inhibits malignant cell transformation.
+
[https://www.uniprot.org/uniprot/BIN1_HUMAN BIN1_HUMAN] May be involved in regulation of synaptic vesicle endocytosis. May act as a tumor suppressor and inhibits malignant cell transformation.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 23: Line 24:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Balbach, J]]
+
[[Category: Balbach J]]
-
[[Category: Loew, C]]
+
[[Category: Loew C]]
-
[[Category: Weininger, U]]
+
[[Category: Weininger U]]
-
[[Category: Alternative splicing]]
+
-
[[Category: Anti-oncogene]]
+
-
[[Category: Barpeptide]]
+
-
[[Category: Cell cycle]]
+
-
[[Category: Coiled coil]]
+
-
[[Category: Cytoplasm]]
+
-
[[Category: Developmental protein]]
+
-
[[Category: Differentiation]]
+
-
[[Category: Endocytosis]]
+
-
[[Category: Host-virus interaction]]
+
-
[[Category: Micelle]]
+
-
[[Category: Nmr-structure]]
+
-
[[Category: Nucleus]]
+
-
[[Category: Phosphoprotein]]
+
-
[[Category: Sh3 domain]]
+

Current revision

Structure of the N-terminal BARpeptide in SDS micelles

PDB ID 2rmy

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools